SNWV News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

SN

Mkt Cap

$44.5M

Volume

44.60K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Sanuwave Announces Q2 FY2026 Financial ResultsSanuwave Health (NASDAQ: SNWV) reported Q2 2026 revenues of $9.7 million, down 3% year-over-year, with gross margins declining to 76.2% from 78.1%. The company posted an operating loss of $0.3 million versus operating income of $1.4 million in Q2 2025. While Ultramist applicator revenue grew 13%, system sales declined significantly due to CMS reimbursement pressures and a secondary market for used equipment. The company has withdrawn its 2026 guidance pending clarity on Medicare reimbursement developments.GlobeNewswire Inc. · Aug 6, 2026

Sanuwave Announces Revenues and Financial Results for Q1 FY2026Sanuwave Health (NASDAQ: SNWV) reported Q1 2026 revenues of $9.6 million, up 3.1% from $9.3 million in Q1 2025, marking the highest Q1 quarterly revenue in company history. However, gross margin declined to 77.3% from 79.0% due to wholesale pricing for resellers. The company swung to a $1.1 million operating loss from $0.6 million operating income in the prior year. Management expressed optimism about recovery beginning in February, with consumables unit volumes reaching all-time records. The company guides for Q2 2026 revenue growth of 10-15% and full-year 2026 growth of 16-25%.GlobeNewswire Inc. · May 12, 2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial ResultsSanuwave Health, Inc. (NASDAQ: SNWV) announced it will host a conference call on May 13, 2026 at 8:30 AM ET to present Q1 2026 financial results. The company reported preliminary Q1 2026 revenue of $9.6-$9.7 million, representing a 3-4% year-over-year increase.GlobeNewswire Inc. · May 6, 2026

Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-YearSanuwave Health reported Q1 2026 preliminary revenues of $9.6-$9.7 million, representing 3-4% growth over Q1 2025 and in line with guidance. The company attributed lower-than-midpoint results to deals sliding out of the quarter due to reimbursement changes in the wound care space affecting skin substitutes and allografts. CEO Morgan Frank expressed cautious optimism about market recovery, noting strong interest in Sanuwave's Ultramist product at the SAWC conference.GlobeNewswire Inc. · Apr 16, 2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025Sanuwave Health announced record Q4 2025 revenues of $13.4 million (up 29.7% YoY) and full year 2025 revenues of $44.1 million (up 35% YoY). The company achieved record quarterly and annual results driven by UltraMist system sales (255 units in Q4, 624 for full year) and consumables revenue growth. Gross margin improved to 77.1% for full year 2025. The company issued Q1 2026 guidance of $9.6-10.3 million (3-10% growth) and full year 2026 guidance of $51.0-55.0 million (16-25% growth).GlobeNewswire Inc. · Mar 26, 2026

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceSanuwave Health, a wound care products company, will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12-15, 2026, offering meetings with company management.GlobeNewswire Inc. · Dec 10, 2025

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupplySanuwave Health has added its UltraMIST product line to Healogics iSupply Group Purchasing Organization, expanding access for wound care centers, home health agencies, and skilled nursing facilities.GlobeNewswire Inc. · Dec 8, 2025

CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)Sanuwave Health announced that CMS's 2026 Physician Fee Schedule for UltraMIST procedure (CPT code 97610) remains largely unchanged, with reimbursement rates staying within $2-4 of 2025 levels.GlobeNewswire Inc. · Nov 3, 2025

Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED)U.S. stock futures fell on Tuesday, with market attention focused on potential Federal Reserve rate cuts and ongoing government shutdown. Key companies like AMD and Trilogy Metals saw significant stock movements due to strategic developments.Benzinga · Oct 7, 2025

3 Lesser-Known Healthcare Names With Major Upside in StoreThe global healthcare market is expected to grow significantly, with three lesser-known companies showing promising potential: Sanuwave Health, Amneal Pharmaceuticals, and Belite Bio, each offering unique strengths in medical technology and pharmaceuticals.Investing.com · Oct 2, 2025

SN

SNWVSANUWAVE Health, Inc. Common Stock

SNWV

Pay with—

Available Balance0.00

Your PositionYou don't own any SNWV yet.

Related Tickers

Earnings